Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib

SIMPLE SUMMARY: Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling is associated with an increased risk of thromboembolic and bleeding complications in cancer patients and may cause fatal side effects. The multityrosine kinase inhibitor sorafenib represents an important trea...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Pomej, Katharina, Scheiner, Bernhard, Park, Dabin, Bauer, David, Balcar, Lorenz, Meischl, Tobias, Mandorfer, Mattias, Reiberger, Thomas, Müller, Christian, Trauner, Michael, Pinter, Matthias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7602103/
https://ncbi.nlm.nih.gov/pubmed/33066190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102961
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia